Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

3 strengths of ranitidine among final 18 price concessions for October

The Department of Health and Social Care and the National Assembly for Wales have agreed concessionary prices for the following 18 items for October 2019 prescriptions.

An initial nine price concessions for the month were announced on October 21 and a further 13 concessionary prices were agreed on October 24.

Drug
Strength
Form
Price
Amiloride
5mg
tablets (28)
£17.96
Cefalexin
125mg/5ml
oral suspension (100ml)
£1.95
Cefalexin
250mg/5ml
oral suspension (100ml)
£2.25
Frovatriptan
2.5mg
tablets (6)
£12.04
Irbesartan
75mg
tablets (28)
£2.78
Irbesartan/ hydrochlorothiazide
300mg/12.5mg
tablets (28)
£14.31
Lamotrigine
25mg
sugar-free dispersible tablets (56)
£23.53
Lamotrigine
100mg
sugar-free dispersible tablets (56)
£7.47
Levetiracetam
500mg
tablets (60)
£8.07
Levetiracetam
1g
tablets (60)
£9.73
Memantine
10mg
tablets (28)
£4.00
Memantine
20mg
tablets (28)
£8.99
Nifedipine
5mg
capsules (90)
£51.95
Nifedipine
10mg
capsules (90)
£65.63
Quetiapine
25mg
tablets (60)
£3.23
Ranitidine
150mg
tablets (60)
£2.49
Ranitidine
300mg
tablets (30)
£2.49
Ranitidine
75mg/5ml
sugar-free oral solution (300ml)
£6.84

As all unexpired stock of certain batches of ranitidine medicines have been recalled due to possible contamination, what advice should you give patients? Read C+D's unplanned learning module

Do these prices reflect the ones you have paid in October so far?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD006174

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel